Clinical and research tests for 5290 - Genetic Testing Registry (GTR)

<< First< Prev

Page 1 of 12

Results: 1 to 20 of 231

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
NGS Oncology Melanoma Profile (Tissue Only) Diagnostic Laboratory Services, Inc. United States	1	41	C Sequence analysis of the entire coding region
Guardant360 TissueNext Guardant Health United States	1	85	M Methylation analysis I Microsatellite instability testing (MSI) E Sequence analysis of select exons T Targeted variant analysis
Guardant360 Response Guardant Health United States	1	74	E Sequence analysis of select exons T Targeted variant analysis
NeXT Dx Personalis, Inc. United States	1	413	I Microsatellite instability testing (MSI) R RNA analysis C Sequence analysis of the entire coding region
Guardant360 Guardant Health United States	1	84	I Microsatellite instability testing (MSI) E Sequence analysis of select exons T Targeted variant analysis
Tempus xT Tempus AI - RTP United States	2	647	I Microsatellite instability testing (MSI) C Sequence analysis of the entire coding region
PIK3CA Gene Cowden syndrome type 5 NGS Genetic DNA Test DNA Labs India India	1	1	S Mutation scanning of the entire coding region
NGS Oncology Tumor Profile Diagnostic Laboratory Services, Inc. United States	5	40	C Sequence analysis of the entire coding region
Tempus xT Tempus AI - CHI United States	2	647	I Microsatellite instability testing (MSI) C Sequence analysis of the entire coding region
FoundationOne® Heme Foundation Medicine, Inc. United States	2	405	D Deletion/duplication analysis R RNA analysis E Sequence analysis of select exons C Sequence analysis of the entire coding region
Tempus xF Tempus AI - RTP United States	1	105	I Microsatellite instability testing (MSI) C Sequence analysis of the entire coding region
NEXT GEN SEQUENCING COMPREHENSIVE SOLID TUMOR PANEL Alverno Laboratories United States	1	27	T Targeted variant analysis
Cell-Free DNA PIK3CA Test, Blood Mayo Clinic Laboratories Mayo Clinic United States	1	1	T Targeted variant analysis
PIK3CA Mutation Analysis, Tumor Mayo Clinic Laboratories Mayo Clinic United States	1	1	T Targeted variant analysis
OnkoSight Advanced Bladder Cancer Panel BioReference Health United States	1	39	C Sequence analysis of the entire coding region
OnkoSight Advanced Breast Cancer Panel BioReference Health United States	1	50	C Sequence analysis of the entire coding region
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States	16	160	T Targeted variant analysis
CentoCancer Comprehensive Centogene AG - the Rare Disease Company Germany	155	107	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Solid Tumor Panel Centogene AG - the Rare Disease Company Germany	218	135	C Sequence analysis of the entire coding region
PIK3CA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany	14	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 12

Next >Last >>

Results: 1 to 20 of 231

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Filters

Test type

Test purpose

Test method

Biochemical Genetics

Cytogenetics

Molecular Genetics

Test service

Laboratory certification

Specimen type

Laboratory location

Other countries

Results: 1 to 20 of 231

Results: 1 to 20 of 231